From Thursday 29th November, adrenaline 150microgram auto-injectors are no longer be subject to additional validation processes.
The Department of Health and Social Care (DHSC) has stated that stock levels are now at a level where the validation protocol is no longer required.*
Dispensers are now permitted to dispense the total number of adrenaline 150microgram auto-injectors prescribed to each patient. However, whilst stock filters through the supply chain, some wholesalers may still apply a restriction to ordering levels.
* EpiPen products were subject to prescription validation prior to the protocol introduced October and this will continue as before.